Related references
Note: Only part of the references are listed.Justification for the inclusion of Gag in HIV vaccine candidates
Anna-Lise Williamson et al.
EXPERT REVIEW OF VACCINES (2016)
New Member of the V1V2-Directed CAP256-VRC26 Lineage That Shows Increased Breadth and Exceptional Potency
Nicole A. Doria-Rose et al.
JOURNAL OF VIROLOGY (2016)
Structures of HIV-1 Env V1V2 with broadly neutralizing antibodies reveal commonalities that enable vaccine design
Jason Gorman et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2016)
Structures of HIV-1 Env V1V2 with broadly neutralizing antibodies reveal commonalities that enable vaccine design
Jason Gorman et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2016)
Impact of HIV infection on the haemostatic response during sepsis and malaria
Michaela A. M. Huson et al.
BRITISH JOURNAL OF HAEMATOLOGY (2016)
Maturation Pathway from Germline to Broad HIV-1 Neutralizer of a CD4-Mimic Antibody
Mattia Bonsignori et al.
CELL (2016)
l Trimeric HIV-1-Env Structures Define Glycan Shields from Clades A, B, and G
Guillaume B. E. Stewart-Jones et al.
CELL (2016)
The Latent Reservoir for HIV-1: How Immunologic Memory and Clonal Expansion Contribute to HIV-1 Persistence
Alexandra J. Murray et al.
JOURNAL OF IMMUNOLOGY (2016)
Achieving Potent Autologous Neutralizing Antibody Responses against Tier 2 HIV-1 Viruses by Strategic Selection of Envelope Immunogens
Ann J. Hessell et al.
JOURNAL OF IMMUNOLOGY (2016)
Mosaic H5 Hemagglutinin Provides Broad Humoral and Cellular Immune Responses against Influenza Viruses
Attapon Kamlangdee et al.
JOURNAL OF VIROLOGY (2016)
Development of Broadly Neutralizing Antibodies and Their Mapping by Monomeric gp120 in Human Immunodeficiency Virus Type 1-Infected Humans and Simian-Human Immunodeficiency Virus SHIVSF162P3N-Infected Macaques
Manxue Jia et al.
JOURNAL OF VIROLOGY (2016)
Increased Valency of Conserved-mosaic Vaccines Enhances the Breadth and Depth of Epitope Recognition
Sultan Abdul-Jawad et al.
MOLECULAR THERAPY (2016)
Novel Conserved-region T-cell Mosaic Vaccine With High Global HIV-1 Coverage Is Recognized by Protective Responses in Untreated Infection
Beatrice Ondondo et al.
MOLECULAR THERAPY (2016)
Antiretroviral Therapy for the Prevention of HIV-1 Transmission
M. S. Cohen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Envelope residue 375 substitutions in simian-human immunodeficiency viruses enhance CD4 binding and replication in rhesus macaques
Hui Li et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Broadly targeted CD8+ T cell responses restricted by major histocompatibility complex E
Scott G. Hansen et al.
SCIENCE (2016)
Persistent HIV-1 replication during antiretroviral therapy
Javier Martinez-Picado et al.
CURRENT OPINION IN HIV AND AIDS (2016)
Epigraph: A Vaccine Design Tool Applied to an HIV Therapeutic Vaccine and a Pan-Filovirus Vaccine
James Theiler et al.
SCIENTIFIC REPORTS (2016)
Holes in the Glycan Shield of the Native HIV Envelope Are a Target of Trimer-Elicited Neutralizing Antibodies
Laura E. McCoy et al.
CELL REPORTS (2016)
Optimal Combinations of Broadly Neutralizing Antibodies for Prevention and Treatment of HIV-1 Clade C
Kshitij Wagh et al.
PLOS PATHOGENS (2016)
A Multi-Component Prime-Boost Vaccination Regimen with a Consensus MOMP Antigen Enghances Chlamydia trachomatis Clearance
Alexander Badamchi-Zadeh et al.
FRONTIERS IN IMMUNOLOGY (2016)
Structural Repertoire of HIV-1-Neutralizing Antibodies Targeting the CD4 Supersite in 14 Donors
Tongqing Zhou et al.
CELL (2015)
Comparison of Immunogenicity in Rhesus Macaques of Transmitted-Founder, HIV-1 Group M Consensus, and Trivalent Mosaic Envelope Vaccines Formulated as a DNA Prime, NYVAC, and Envelope Protein Boost
Sandrine L. Hulot et al.
JOURNAL OF VIROLOGY (2015)
Burden of tuberculosis at post mortem in inpatients at a tertiary referral centre in sub-Saharan Africa: a prospective descriptive autopsy study
Matthew Bates et al.
LANCET INFECTIOUS DISEASES (2015)
Antibody responses to envelope glycoproteins in HIV-1 infection
Dennis R. Burton et al.
NATURE IMMUNOLOGY (2015)
Viral variants that initiate and drive maturation of V1V2-directed HIV-1 broadly neutralizing antibodies
Jinal N. Bhiman et al.
NATURE MEDICINE (2015)
Effect of the cytoplasmic domain on antigenic characteristics of HIV-1 envelope glycoprotein
Jia Chen et al.
SCIENCE (2015)
Longitudinal Antigenic Sequences and Sites from Intra-Host Evolution (LASSIE) Identifies Immune-Selected HIV Variants
Peter Hraber et al.
VIRUSES-BASEL (2015)
Vaccine-Elicited Tier 2 HIV-1 Neutralizing Antibodies Bind to Quaternary Epitopes Involving Glycan-Deficient Patches Proximal to the CD4 Binding Site
Ema T. Crooks et al.
PLOS PATHOGENS (2015)
Human Non-neutralizing HIV-1 Envelope Monoclonal Antibodies Limit the Number of Founder Viruses during SHIV Mucosal Infection in Rhesus Macaques
Sampa Santra et al.
PLOS PATHOGENS (2015)
Complete epitopes for vaccine design derived from a crystal structure of the broadly neutralizing antibodies PGT128 and 8ANC195 in complex with an HIV-1 Env trimer
Leopold Kong et al.
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY (2015)
Polyreactivity and Autoreactivity among HIV-1 Antibodies
Mengfei Liu et al.
JOURNAL OF VIROLOGY (2015)
Cooperation of B Cell Lineages in Induction of HIV-1-Broadly Neutralizing Antibodies
Feng Gao et al.
CELL (2014)
Pathogen-like particles: biomimetic vaccine carriers engineered at the nanoscale
Joseph A. Rosenthal et al.
CURRENT OPINION IN BIOTECHNOLOGY (2014)
Antiretroviral Treatment of Adult HIV Infection 2014 Recommendations of the International Antiviral Society-USA Panel
Huldrych F. Guenthard et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2014)
Progress in HIV-1 vaccine development
Barton F. Haynes et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2014)
Recombinant adenovirus type 5 HIV gag/pol/nef vaccine in South Africa: unblinded, long-term follow-up of the phase 2h HVTN 503/Phambili study
Glenda E. Gray et al.
LANCET INFECTIOUS DISEASES (2014)
Immunological and virological mechanisms of vaccine-mediated protection against SIV and HIV
Mario Roederer et al.
NATURE (2014)
Safety and Tolerability of Conserved Region Vaccines Vectored by Plasmid DNA, Simian Adenovirus and Modified Vaccinia Virus Ankara Administered to Human Immunodeficiency Virus Type 1-Uninfected Adults in a Randomized, Single-Blind Phase I Trial
Emma-Jo Hayton et al.
PLOS ONE (2014)
HIV-1 Conserved Elements p24CE DNA Vaccine Induces Humoral Immune Responses with Broad Epitope Recognition in Macaques
Viraj Kulkarni et al.
PLOS ONE (2014)
Affinity maturation in an HIV broadly neutralizing B-cell lineage through reorientation of variable domains
Daniela Fera et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Recent Developments in Preclinical DNA Vaccination
Kenji Okuda et al.
VACCINES (2014)
Immune System Regulation in the Induction of Broadly Neutralizing HIV-1 Antibodies
Garnett Kelsoe et al.
VACCINES (2014)
Protective Efficacy of a Global HIV-1 Mosaic Vaccine against Heterologous SHIV Challenges in Rhesus Monkeys
Dan H. Barouch et al.
CELL (2013)
Hepatitis C Genotype 1 Mosaic Vaccines Are Immunogenic in Mice and Induce Stronger T-Cell Responses than Natural Strains
Karina Yusim et al.
CLINICAL AND VACCINE IMMUNOLOGY (2013)
Translating HIV Sequences into Quantitative Fitness Landscapes Predicts Viral Vulnerabilities for Rational Immunogen Design
Andrew L. Ferguson et al.
IMMUNITY (2013)
Co-evolution of a broadly neutralizing HIV-1 antibody and founder virus
Hua-Xin Liao et al.
NATURE (2013)
Supersite of immune vulnerability on the glycosylated face of HIV-1 envelope glycoprotein gp120
Leopold Kong et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2013)
Efficacy Trial of a DNA/rAd5 HIV-1 Preventive Vaccine
Scott M. Hammer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Cytomegalovirus Vectors Violate CD8+ T Cell Epitope Recognition Paradigms
Scott G. Hansen et al.
SCIENCE (2013)
A Next-Generation Cleaved, Soluble HIV-1 Env Trimer, BG505 SOSIP.664 gp140, Expresses Multiple Epitopes for Broadly Neutralizing but Not Non-Neutralizing Antibodies
Rogier W. Sanders et al.
PLOS PATHOGENS (2013)
Vaccine delivery using nanoparticles
Anthony E. Gregory et al.
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2013)
T cells induced by recombinant chimpanzee adenovirus alone and in prime-boost regimens decrease chimeric EcoHIV/NDK challenge virus load
Yaowaluck Roshorm et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2012)
Distinct Evolutionary Pressures Underlie Diversity in Simian Immunodeficiency Virus and Human Immunodeficiency Virus Lineages
Will Fischer et al.
JOURNAL OF VIROLOGY (2012)
Full-Length HIV-1 Immunogens Induce Greater Magnitude and Comparable Breadth of T Lymphocyte Responses to Conserved HIV-1 Regions Compared with Conserved-Region-Only HIV-1 Immunogens in Rhesus Monkeys
Kathryn E. Stephenson et al.
JOURNAL OF VIROLOGY (2012)
Broad and potent neutralization of HIV-1 by a gp41-specific human antibody
Jinghe Huang et al.
NATURE (2012)
Immune-Correlates Analysis of an HIV-1 Vaccine Efficacy Trial
Barton F. Haynes et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Designing and Testing Broadly-Protective Filoviral Vaccines Optimized for Cytotoxic T-Lymphocyte Epitope Coverage
Paul W. Fenimore et al.
PLOS ONE (2012)
Breadth of cellular and humoral immune responses elicited in rhesus monkeys by multi-valent mosaic and consensus immunogens
Sampa Santra et al.
VIROLOGY (2012)
Early Low-Titer Neutralizing Antibodies Impede HIV-1 Replication and Select for Virus Escape
Katharine J. Bar et al.
PLOS PATHOGENS (2012)
Definition of the viral targets of protective HIV-1-specific T cell responses
Beatriz Mothe et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2011)
Profound early control of highly pathogenic SIV by an effector memory T-cell vaccine
Scott G. Hansen et al.
NATURE (2011)
Focused Evolution of HIV-1 Neutralizing Antibodies Revealed by Structures and Deep Sequencing
Xueling Wu et al.
SCIENCE (2011)
HIV-1 Vaccine Development After STEP
Dan H. Barouch et al.
ANNUAL REVIEW OF MEDICINE (2010)
Early Selection in Gag by Protective HLA Alleles Contributes to Reduced HIV-1 Replication Capacity That May Be Largely Compensated for in Chronic Infection
Mark A. Brockman et al.
JOURNAL OF VIROLOGY (2010)
Mosaic HIV-1 vaccines expand the breadth and depth of cellular immune responses in rhesus monkeys
Dan H. Barouch et al.
NATURE MEDICINE (2010)
Mosaic vaccines elicit CD8+ T lymphocyte responses that confer enhanced immune coverage of diverse HIV strains in monkeys
Sampa Santra et al.
NATURE MEDICINE (2010)
Transmission of Single HIV-1 Genomes and Dynamics of Early Immune Escape Revealed by Ultra-Deep Sequencing
Will Fischer et al.
PLOS ONE (2010)
The role of recombination in the emergence of a complex and dynamic HIV epidemic
Ming Zhang et al.
RETROVIROLOGY (2010)
Structural Basis for Broad and Potent Neutralization of HIV-1 by Antibody VRC01
Tongqing Zhou et al.
SCIENCE (2010)
The first T cell response to transmitted/founder virus contributes to the control of acute viremia in HIV-1 infection
Nilu Goonetilleke et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2009)
T-Cell Vaccine Strategies for Human Immunodeficiency Virus, the Virus with a Thousand Faces
Bette T. Korber et al.
JOURNAL OF VIROLOGY (2009)
Immune control of an SIV challenge by a T-cell-based vaccine in rhesus monkeys
Jinyan Liu et al.
NATURE (2009)
Vaccination with ALVAC and AIDSVAX to Prevent HIV-1 Infection in Thailand
Supachai Rerks-Ngarm et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Nanotechnology in vaccine delivery
Laura J. Peek et al.
ADVANCED DRUG DELIVERY REVIEWS (2008)
Web-based design and evaluation of T-cell vaccine candidates
James Thurmond et al.
BIOINFORMATICS (2008)
Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial
Susan P. Buchbinder et al.
LANCET (2008)
Safety and immunogenicity of cytotoxic T-lymphocyte poly-epitope, DNA plasmid (EP HIV-1090) vaccine in healthy, human immunodeficiency virus type 1 (HIV-1)-uninfected adults
Geoffrey J. Gorse et al.
VACCINE (2008)
Safety and immunogenicity of recombinant low-dosage HIV-1 a vaccine candidates vectored by plasmid pTHr DNA or modified vaccinia virus Ankara (MVA) in humans in East Africa
Walter Jaoko et al.
VACCINE (2008)
Design and Pre-Clinical Evaluation of a Universal HIV-1 Vaccine
Sven Letourneau et al.
PLOS ONE (2007)
Polyvalent vaccines for optimal coverage of potential T-cell epitopes in global HIV-1 variants
Will Fischer et al.
NATURE MEDICINE (2007)
Optimization and delivery of plasmid DNA for vaccination
Wolfgang Jechlinger
EXPERT REVIEW OF VACCINES (2006)
Polyvalent HIV-1 Env vaccine formulations delivered by the DNA priming plus protein boosting approach are effective in generating neutralizing antibodies against primary human immunodeficiency virus type 1 isolates from subtypes A, B, C, D and E
Shixia Wang et al.
VIROLOGY (2006)
AIDS - Diversity considerations in HIV-1 vaccine selection
B Gaschen et al.
SCIENCE (2002)
Share Paper
